# Bio‑Aug: Biocompatible Autonomy & Security Layer for Augmented Users

Bio‑Aug is a research-grade, rights-first framework for building secure, medically informed interfaces between biological tissue and digital systems — including AI, neuromorphic devices, and cybernetic implants. It is designed as a policy-first control plane which: (a) enforces rigorous human-rights and safety constraints; (b) enables simulation-first verification; and (c) keeps actuation and other high-risk functions strictly gated and auditable.

> Important: Bio‑Aug is a specification, a research framework, and a set of safety-first design patterns. It is not a medical device or clinical product by itself. Any real-world deployments or clinical use require appropriate regulatory approvals, medical device certification, and clinical human trials.

---

## Executive Summary

Bio‑Aug defines a non-wearable, platform-agnostic safety and policy layer for in-body and on-body augmentations. It prioritizes:

- Biocompatibility and medical-grade materials (ISO 10993, implementation guidance noted below).
- Separation of sensing and actuation by default, with strict human-in-the-loop (HITL) and governance controls before enabling any actuation.
- Rights-preserving and audit-first behavior for all telemetry, policies, and governance actions.
- Simulation-first testing (digital twins, in-silico validation) as a precondition for real-world deployment.

The architecture maps cleanly to the ALN (Augmented Language of National/Notation) specification in this repository. ALN expresses declarative policies and constraints that compile to deterministic safety guards in the runtime kernel.

---

## Scope & Intended Use

Bio‑Aug is intended for research, standardization, and early-stage development that intersects biomechanical engineering, BCI, AI, and clinical safety engineering. The project focuses on:

- Research prototypes, simulation platforms (Unreal, Unity, Godot) and verification toolchains for safety-critical components.
- Reference implementations in safe languages (Rust for real-time and kernel code; Go for services; ALN for policy layer). No production medical device should be built from these artifacts without full compliance and regulatory certification.

Out-of-scope:

- Direct claims to clinically validated devices or medical recommendations.
- Uncontrolled actuation in humans without explicit, approved, regulatory pathways and multi-party clinical oversight.

---

## Core Design Principles

1. Biocompatible First: All in-body materials and device designs should align with ISO 10993 and medical-grade materials recommendations. Safety trumps functionality.

2. Security by Hard Separation: Strict cross-layer separation is enforced between biological, cybernetic, digital/AI, and simulated layers, using hardware and policy barriers.

3. Malware-Proof by Architecture: No untrusted network code path may reach actuation primitives; dynamic code loading or remote-by-policy actuation is prohibited without regulatory-signed policies.

4. Human Autonomy and Consent: Human subjects keep enforceable rights to consent, audit, opt-out, and full transparency.

5. Public Compliance and Governance-Ready: Designed with regulators, clinicians, and ethics boards in mind; full audit logging and rights-enforcement are core requirements.

---

## High-Level Architecture (for AU.BioMechDigestPipeline.v1 reference)

- Global Safety Core: Auditing, oversight committee and rights enforcement (ETHCORE, RIGHTS, GOVBUS), and a failsafe lockdown policy for anomalies.
- BCI Sensor Layer: Read-only neuromorphic meshes, hepatic patches, and vagal comfort interfaces for physiological monitoring and non-invasive anti-nausea intervention. No actuation without HITL.
- Digestive Digital Twin: A high-fidelity predictive model updating from chaos-resistant sensor inputs, maintained in simulation-only mode or HITL-gated state changes.
- Pre-Digest Reactor: A smart external reactor to reduce harsh in-body decomposition—simulation-first and HACCP-compliant.
- Nausea Control Orchestrator: Recommends actions (e.g., adjust pre-digest protocol, micro-stimulation plan) with strict double-signature HITL gating for any neuromodulation change.
- Metabolic-to-ALN Tokenization: ALN‑20 tokenized accounting for verified metabolic energy yield, non-transferable and auditable, with ledger and audit anchoring.
- Rights and Boundary Guard: Enforceable rights, boundary separation, and safe removal workflows in case of violation.

---

## Safety & Ethics (Key Controls)

- HITL for actuation: All stimulation or actuation requires clinician and patient authorization tokens, logged immutably.
- No autonomous medication orders: Recommendations may be proposed but never directly written to EHRs or medication management systems without multi-party signed approval.
- Immutable Audit Logging: All critical events and token minting actions must be written to an immutable audit sink.
- Simulation & Sandbox Policy: Research Sandbox mode must use simulated inputs only, and keep tokens shadowed.
- Fail-safe Lockdown: A defined controlplane fallback closes actuation and tokenization on policy breach or audit failure.

---

## Legal & Regulatory Pathways (Guidance)

Bio‑Aug is not a regulatory body. The components in this repository are designed to be compatible with and supportive of medical device certification and cybersecurity-required standards, but they are not a substitute for regulatory compliance. Implementation teams should align with:

- IEC 62304 (medical device software lifecycle and safety classification).
- ISO 14971 (medical device risk management).
- ISO 10993 (biocompatibility evaluation of medical devices).
- FDA (USA) 510(k)/De Novo/PMA and Breakthrough Device Program guidelines depending on device risk classification.
- EU MDR (CE route) and associated MDCG guidance for cybersecurity and post-market surveillance.

Before any clinical or real-world deployment, teams must convene regulatory consultants and clinical partners to formalize path-to-market and safety justification documents.

---

## Simulation-First Mandate

No code or policy which affects actuation should be deployed without passing thorough simulation-based stress scenarios involving:

- Long-horizon digestion sequences (healthy, disease, postoperative states).
- Best/worst-case device failures (partial short, corrosion, sensor exchange failure).
- Adversarial inputs and failure-mode scenarios (anomalous telemetry, rate-limiting overloads).

All simulation runs are archived to permit forensic review and reproducibility; changes to policies or device parameters require new simulation proofs.

---

## Implementation Guidance & Languages

- Runtime kernel and BCI drivers: Rust (no_std for deeply embedded, with hardware-backed signatures).
- Services and low-latency backend: Go (for concurrency and secure service patterns).
- Policy grammar: ALN for human readable safety policies binding physical, semantic and regulatory contracts.
- Sim & Engine integration: FFI wrappers and language bindings (C# for Unity, C++ for Unreal, Godot bindings).

Coding and build guidance:

- Use clippy/rustfmt/golangci-lint and enforce SAST/DAST in CI/CD.
- Use remote build agents in CI/CD for deterministic builds.

---

## Data & Interoperability

Bio‑Aug encourages data standards that enable vendor-neutral device interchange and EHR integration:

- Device telemetry on constrained links: ISO/IEEE 11073 (SDC profiles) for device and metric models.
- At-rest and EHR integration: HL7 FHIR (Device, Observation, DeviceMetric), along with defined ALN mappings.
- Notification & alarm semantics: Use SDC/SDPi and IHE PCD for alarm, status, and event semantics.

---

## Contributions and Governance

This repository welcomes contributions that align with the mission, scope, and safety-first principles. We expect contributors to comply with the following:

- Submit proposals through our standard PR & issue process with reproducible simulation scenarios and unit tests.
- Include SBOM references and risk assessments for any new code or device descriptor.
- No Python in the runtime kernel path; we prefer Rust for kernel and Go for services.
- Policy bundles (ALN) must be signed and reviewable by the governance council before they are accepted to the canonical branch.

---

## Disclaimers & Non-Clinical Use

- This repository contains research artifacts, policy grammar, and simulation code only. Nothing here is intended to substitute for medical advice or to be used to operate real-world devices absent completed regulatory steps.
- All acts of physical, medical, or implantable device construction and deployment are subject to medical institutional review boards, clinical trials, and formal industrial and regulatory oversight.
- This project does not grant medical training or device certification; it is a research, design, and standards reference.

---

## License and Code of Conduct

- Default license: Apache-2.0 (or MIT — checked in your repository as the project policy defines; adjust per your organization choices). We recommend permissive licensing for reference implementations intended for adoption.
- Contributions require signed Contributor License Agreements (CLAs) and a documented chain of custody for SBOMs and dependencies.

---

## Quick Links

- ALN spec: `/futuretech/augmented-digestion/ALN20_biomech_digest_pipeline.aln` (core pipeline)
- ALN meta-language: `/ALN/ALN_Biomech_Interop_Directives.aln` (interfaces and mapping)
- Design notes: `/docs/augmented-digestion/Design_Notes_AU_BioMechDigest_ALN20.md`

## BioAugClinical (Regulatory Profile)

BioAugClinical validation runs target **IEC 62304 Class C** safety standards and uses ISO 14971 hazard mappings. To validate ALN files against the BioAugClinical profile locally, run:

```
# Build aln-cli
cd aln-cli && cargo build --release
./aln-cli/target/release/aln validate <file>.aln --profile bioaug-clinical
```

ALN artifacts that influence actuation or therapy must include `traceability` annotations and be signed by CLINICAL_POLICY + SECURITY_POLICY prior to merge.

---

## Contact & Governance

For collaborating or adopting Bio‑Aug, join or contact our governance group with stakeholders from: regulatory bodies, clinical experts, device manufacturers, patient advocates, and the technical steering committee. We publish governance notes and meeting minutes in the repository's `governance/` folder.

---

## Acknowledgements

This design builds on existing standards and domain knowledge in medical device engineering, neuromorphic research, biosensing, and human rights best practices. We encourage review from domain experts in biomechanics, clinical medicine, device safety, and ethics.

---

Thank you for contributing to safer augmentation and the ethical integration of AI with biomechanical systems.

---

## Security & Disclosure

If you have discovered a security issue or incident affecting Bio‑Aug, please report it via the security contact defined in `SECURITY_CONTACT`. For sensitive reports, use the PGP key in `SECURITY_PGP_KEY.asc` for encrypted disclosure. We aim to acknowledge all disclosures within 48 hours and set coordinated disclosure timelines with reporters and affected vendors.

See `SECURITY.md` for the full reporting process and timelines.
